Medical Imaging London Limited 10712480 true 2023-05-01 2024-04-30 2024-04-30 The principal activity of the company is that of a dormant company. Digita Accounts Production Advanced 6.30.9574.0 true C McLean false true 10712480 2023-05-01 2024-04-30 10712480 2024-04-30 10712480 bus:OrdinaryShareClass1 bus:OtherShareType 2024-04-30 10712480 core:ShareCapital 2024-04-30 10712480 bus:FRS102 2023-05-01 2024-04-30 10712480 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 10712480 bus:FullAccounts 2023-05-01 2024-04-30 10712480 bus:RegisteredOffice 2023-05-01 2024-04-30 10712480 bus:Director1 2023-05-01 2024-04-30 10712480 bus:OrdinaryShareClass1 bus:OtherShareType 2023-05-01 2024-04-30 10712480 bus:EntityHasNeverTraded 2023-05-01 2024-04-30 10712480 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 10712480 1 2023-05-01 2024-04-30 10712480 countries:EnglandWales 2023-05-01 2024-04-30 10712480 2022-05-01 2023-04-30 10712480 2023-04-30 10712480 bus:OrdinaryShareClass1 bus:OtherShareType 2023-04-30 10712480 core:ShareCapital 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10712480

Medical Imaging London Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 April 2024

 

Medical Imaging London Limited

Profit and Loss Account for the Year Ended 30 April 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Medical Imaging London Limited

(Registration number: 10712480)
Balance Sheet as at 30 April 2024

Note

2024
£

2023
£

Current assets

 

Cash at bank and in hand

 

2

2

Capital and reserves

 

Called up share capital

4

2

2

Shareholders' funds

 

2

2

For the financial year ending 30 April 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 24 February 2025
 


C McLean
Director

 

Medical Imaging London Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 7 The Pavilions
Brighton Road
Crawley
West Sussex
RH11 9BJ

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or key sources of estimation uncertainty.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

 

Medical Imaging London Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

2

2

2

2

       

5

Parent and ultimate parent undertaking

The company's immediate parent is Medical Imaging Partnership Limited, incorporated in England and Wales.

 The ultimate parent is Imaging Holdings Company Limited (formerly Apposite Imaging Holdings Company Limited), incorporated in England and Wales.

 The most senior parent entity producing publicly available financial statements is Imaging Holdings Company Limited. These financial statements are available upon request from Companies House.

 The ultimate controlling party is Apposite Capital LLP.